Sophia Guldberg's research focuses on finding ways to cure cancer by restoring a healthy balance in the immune system. She studies how the protein AIRE, also known as the auto immune regulator gene, might inadvertently teach the immune system to tolerate cancer. She recently discovered that removing AIRE from immune cells can promote tumor rejection in mice.
Guldberg was a UCSF Grad Slam 2023 presenter, a competition that challenges PhD students to present a compelling talk on their research in three minutes or less using compelling language that non-specialists can understand.
For students, the contest is an incentive to clarify their ideas and to help others understand and appreciate the significance of their work. For the audience, it's an entertaining glimpse into research graduate students are engaged in. https://graduate.ucsf.edu/grad-slam
View all 10 Grad Slam competition talks: https://www.youtube.com/playlist?list=PLVLbDUiGesPxqpjXZ6PUZOLQ8QPoSQZbk
Sophia Guldberg is part of the UCSF Biomedical Sciences Program,
Matthew Spitzer, PhD, faculty mentor
https://bms.ucsf.edu/
Life is all about balance. We all try to balance
work, family, hobbies and more daily. But today, I want to talk to you
about a balance you probably never think about and your immune system
between rejection and tolerance. This balance is an incredibly complex
process of give and take between the various players of our immune system
and also the key to keeping us healthy. Tip too far towards rejection
and you get autoimmunity or allergies, but tip too far towards tolerance
and you develop cancer
s specifically. In the case of cancers,
the balance has become skewed. So the immune system no longer recognizes
mutated cells as disease and fails to eliminate them. The obvious solution to
this is to restore the balance and help the immune system recognize
the cancer is disease once again. But if it's this simple,
why haven't we cured cancer? We haven't cured cancer because cancer is very good
at disguising itself. And while great advancements
have been made on therapies that enhance our immun
e systems, far too many patients
still die of cancer. I, with the help of my collaborators,
have spent the last several years studying how this healthy balance
tips towards tolerance in cancers through the study of a gene called AIRE,
also known as autoimmune regulator gene. AIRE is known to teach the immune system
to tolerate and recognize healthy cells. This is incredibly important
to establishing immune balance, but I ask the question of whether immune
cells expressing Aire might inadvertentl
y teach the immune system
to tolerate cancer, which, as I previously mentioned, is very good
at disguising itself. At first it wasn't even known that immune cells in a tumor
could express Aire. However, I recently discovered
not only can they express Aire, but that when I eliminate these Aire
expressing immune cells, I can promote tumor rejection
in mouse models of cancer. For our team,
this is an incredibly exciting result because it means that we found a way
to boost the immune system and help
it recognize
the cancer is disease once again. In order to look at these cells
more specifically, I wanted to understand why elimination of air expressing immune
cells is effective at slowing tumor growth and then found that elimination
of these cells allows the remaining immune cells to become less tolerant
and more prone to rejection, enabling them to recognize the cancer
as disease and kill it. Now, knowing that Aire expressing
immune cells are helping to tip
the balance towards tolerance to
cancer, I want to further understand how immune
cells take on this more tolerant role and to understand whether we can target
these Aire expressing immune cells, specifically using therapies already
approved by the FDA in other indications. I hope that our studies will be a breath
of fresh air into the field of cancer therapeutics and allow us to continue
to care more patients of cancer every day. And that is the power of balance. Thank you.
Comments
Fascinating! I'd love to learn more about AIRE, and how it will further advance research into cancer!